Malaria DNA vaccine - Naval Medical Research Center/Vical

Drug Profile

Malaria DNA vaccine - Naval Medical Research Center/Vical

Alternative Names: Malaria DNA vaccine VCL-2510; MuStDO 5; VCL-2510

Latest Information Update: 15 Sep 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Naval Medical Research Center
  • Class Antimalarials; DNA vaccines; Gene therapies; Parasitic vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Malaria

Most Recent Events

  • 15 Sep 2015 No recent reports on development identified - Phase-I/II for Malaria (Prevention, volunteers) in USA (IM)
  • 14 Feb 2013 Malaria DNA vaccine is still in phase I/II trials for Malaria in USA
  • 27 Apr 2010 Malaria DNA vaccine is still in phase I/II clinical development in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top